SightfileU.S. market data from official filings

Companies › CRMD

CORMEDIX INC (CRMD)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001410098 · EDGAR filings · Updated 2026-07-02

CORMEDIX INC (CRMD) has reported institutional ownership of 51.3%, with 185 institutional managers holding positions valued at $275.6M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Institutional ownership
51.3%
Institutional managers
185
Reported 13F value
$275.6M
Insider activity
65 trans.
−$4.53M net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CORMEDIX INC has 185 institutional holders and institutional ownership of 51.3%.

Insider activity

Insiders reported 65 transactions (1 buys, 14 sells) across 11 reporting insiders, with a net reported value of −$4.53M.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2021-01-21 (recurring since 2021-01-21) — source filing. The authoritative details are those stated in the filing itself.

Related companies

INVIVYD INC (IVVD) · FULGENT GENETICS INC (FLGT) · CERUS CORP (CERS) · STANDARD BIOTOOLS INC (LAB) · SAB BIOTHERAPEUTICS INC (SABS) · REZOLUTE INC (RZLT)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-02.